A Study for Type 2 Diabetic Patients

Phase 4 Completed 426 enrolled Eli Lilly and Company

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of the study is to compare the insulin lispro low mixture (1, 2 or 3 daily injections) with insulin glargine (alone or with 1, 2 or 3 insulin lispro daily injections) on lowering the blood sugar level

Timeline

Start: 2007-11
Primary completion: 2009-08
Completion: 2009-08

Publications

Bowering K, Reed VA, Felicio JS, Landry J, Ji L, Oliveira J. A study comparing insulin lispro mix 25 with glargine plus lispro therapy in patients with Type 2 diabetes who have inadequate glycaemic control on oral anti-hyperglycaemic medication: results of the PARADIGM study. Diabet Med. 2012 Sep;29(9):e263-72. doi: 10.1111/j.1464-5491.2012.03722.x.

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Insulin Lispro	Protein / enzyme biologic	—	Subcutaneous
Subject	Insulin lispro low mixture	Unknown	—	Subcutaneous
Comparator	insulin glargine	Protein / enzyme biologic	—	Subcutaneous

A Study for Type 2 Diabetic Patients

Summary

Timeline

Publications

Drugs

Indications